Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.07
+0.74 (6.53%)
At close: Mar 6, 2026, 4:00 PM EST
12.00
-0.08 (-0.62%)
After-hours: Mar 6, 2026, 4:10 PM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $400.89 million as of March 6, 2026.
Market Cap
400.89M
Enterprise Value
189.34M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.07
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $400.89M, an increase of 29.83%. That is a compound annual growth rate of 43.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 400.89M | 72.90% |
| Dec 31, 2025 | 231.86M | -24.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 414.45M |
| Upstream Bio | 413.94M |
| DiaMedica Therapeutics | 413.09M |
| Immutep | 408.45M |
| Niagen Bioscience | 406.05M |
| NovaBridge Biosciences | 403.52M |
| Autolus Therapeutics | 401.88M |
| PureTech Health | 400.74M |